Emeritas Research Group LLC

Leesburg, Virginia 20176

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Decompensated Cirrhosis

Studies at this site

• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — Status unconfirmed